TFG Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.7M Sell
3,461
-3
-0.1% -$2.33K 0.92% 25
2025
Q1
$2.86M Buy
3,464
+53
+2% +$44.1K 1.04% 24
2024
Q4
$2.63M Buy
3,411
+77
+2% +$63.8K 0.95% 25
2024
Q3
$2.95M Buy
3,334
+32
+1% +$28.8K 1.06% 24
2024
Q2
$2.99M Buy
3,302
+111
+3% +$88.8K 1.16% 21
2024
Q1
$2.48M Sell
3,191
-38
-1% -$27K 0.97% 24
2023
Q4
$1.88M Buy
3,229
+48
+2% +$28K 0.79% 32
2023
Q3
$1.71M Buy
3,181
+141
+5% +$72.7K 0.8% 35
2023
Q2
$1.43M Sell
3,040
-34
-1% -$14.3K 0.65% 43
2023
Q1
$1.06M Buy
3,074
+15
+0.5% +$5.06K 0.51% 57
2022
Q4
$1.12M Buy
3,059
+2
+0.1% +$709 0.57% 53
2022
Q3
$988K Buy
3,057
+7
+0.2% +$2.22K 0.55% 51
2022
Q2
$989K Hold
3,050
0.53% 54
2022
Q1
$873K Hold
3,050
0.4% 73
2021
Q4
$842K Buy
+3,050
New +$773K 0.37% 75
2020
Q1
Sell
-126
Closed -$16K 315
2019
Q4
$16K Buy
+126
New +$14.6K 0.01% 363

Other funds holding LLY

TFG Advisers's LLY Position: Q2 2025 in Review

TFG Advisers reduced its Eli Lilly (LLY) stake by 0.09% in Q2 2025, selling an estimated $2.33K and leaving 3,461 shares worth $2.7M. The position accounts for 0.92% of the portfolio, ranked #25.

TFG Advisers first reported a position in LLY in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.99M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • TFG Advisers held 3,461 shares of Eli Lilly worth $2.7M as of Q2 2025.
  • TFG Advisers sold 3 Eli Lilly shares in Q2 2025, an estimated $2.33K.
  • Eli Lilly made up 0.92% of TFG Advisers's portfolio in Q2 2025, its #25 holding.
  • TFG Advisers first reported a position in Eli Lilly in Q4 2019 and has held it in 16 quarters since.
  • TFG Advisers's Eli Lilly position peaked at $2.99M in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on TFG Advisers's 13F filing for Q2 2025, filed 21 Jul 2025.